You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 7, July 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Behavioral Neurology
 •Movement Disorders
 •Neuropathology
 •Parkinson Disease/ Parkinsonian Disorders
 •Neurology, Other
 •Nutritional and Metabolic Disorders
 •Metabolism
 •Alert me on articles by topic

Metabolic Alterations in Patients With Parkinson Disease and Visual Hallucinations

Henning Boecker, MD; Andres O. Ceballos-Baumann, MD; Dominik Volk; Bastian Conrad, MD; Hans Forstl, MD; Peter Haussermann, MD

Arch Neurol. 2007;64(7):984-988.

Background  Visual hallucinations (VHs) occur frequently in advanced stages of Parkinson disease (PD). Which brain regions are affected in PD with VH is not well understood.

Objectives  To characterize the pattern of affected brain regions in PD with VH and to determine whether functional changes in PD with VH occur preferentially in visual association areas, as is suggested by the complex clinical symptomatology.

Design  Positron emission tomography measurements using fluorodeoxyglucose F 18. Between-group statistical analysis, accounting for the variance related to disease stage.

Setting  University hospital.

Patients  Eight patients with PD and VH and 11 patients with PD without VH were analyzed. The presence of VH during the month before positron emission tomography was rated using the Neuropsychiatric Inventory subscale for VH (PD and VH, 4.63; PD without VH, 0.00; P < .002).

Results  Parkinson disease with VH, compared with PD without VH, was characterized by reduction in the regional cerebral metabolic rate for glucose consumption (P < .05, corrected for false discovery rate) in occipitotemporoparietal regions, sparing the occipital pole. No significant increase in regional glucose metabolism was detected in patients with PD and VH.

Conclusions  The pattern of resting-state metabolic changes in regions of the dorsal and ventral visual streams, but not in primary visual cortex, in patients with PD and VH, is compatible with the functional roles of visual association areas in higher-order visual processing. These findings may help to further elucidate the functional mechanisms underlying VH in PD.


Author Affiliations: Departments of Nuclear Medicine (Dr Boecker and Mr Volk), Neurology (Drs Ceballos-Baumann and Conrad), and Psychiatry (Dr Forstl), Technische Universität München, München, Germany; and Department of Psychiatry, Christian-Albrechts-Universität zu Kiel, Kiel, Germany (Dr Haussermann). Dr Boecker is now with FE Funktionelle Neurobildgebung, Experimentelle Radiologie, Universitätsklinikum Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.